Detailed information for compound 938188

Basic information

Technical information
  • TDR Targets ID: 938188
  • Name: 2-[6-[(3-iodophenyl)methylamino]purin-9-yl]et hanol
  • MW: 395.198 | Formula: C14H14IN5O
  • H donors: 2 H acceptors: 4 LogP: 1.76 Rotable bonds: 5
    Rule of 5 violations (Lipinski): 1
  • SMILES: OCCn1cnc2c1ncnc2NCc1cccc(c1)I
  • InChi: 1S/C14H14IN5O/c15-11-3-1-2-10(6-11)7-16-13-12-14(18-8-17-13)20(4-5-21)9-19-12/h1-3,6,8-9,21H,4-5,7H2,(H,16,17,18)
  • InChiKey: DNQAXYGECDSJRS-UHFFFAOYSA-N  

Network

Hover on a compound node to display the structore

Synonyms

  • 2-[6-[(3-iodophenyl)methylamino]-9-purinyl]ethanol
  • 2-[6-[(3-iodobenzyl)amino]purin-9-yl]ethanol

Targets

Known targets for this compound

Species Target name Source Bibliographic reference
Rattus norvegicus Adenosine A2a receptor Starlite/ChEMBL References

Predicted pathogen targets for this compound

By orthology
No druggable targets predicted by orthology data
By sequence similarity to non orthologous known druggable targets
Species Potential target Known druggable target Length Alignment span Identity
Schistosoma japonicum ko:K04209 neuropeptide Y receptor, invertebrate, putative Adenosine A2a receptor   410 aa 352 aa 23.6 %
Onchocerca volvulus Mitochondrial inner membrane protein homolog Adenosine A2a receptor   410 aa 340 aa 27.9 %
Schistosoma japonicum ko:K04136 adrenergic receptor, alpha 1b, putative Adenosine A2a receptor   410 aa 366 aa 25.4 %
Onchocerca volvulus Adenosine A2a receptor   410 aa 356 aa 23.9 %
Echinococcus granulosus allatostatin A receptor Adenosine A2a receptor   410 aa 368 aa 22.6 %
Schistosoma japonicum ko:K04135 adrenergic receptor, alpha 1a, putative Adenosine A2a receptor   410 aa 346 aa 28.3 %
Echinococcus multilocularis allatostatin A receptor Adenosine A2a receptor   410 aa 372 aa 22.8 %
Onchocerca volvulus Adenosine A2a receptor   410 aa 337 aa 23.1 %
Echinococcus multilocularis thyrotropin releasing hormone receptor Adenosine A2a receptor   410 aa 342 aa 23.1 %
Echinococcus granulosus thyrotropin releasing hormone receptor Adenosine A2a receptor   410 aa 342 aa 23.1 %
Schistosoma mansoni biogenic amine (5HT) receptor Adenosine A2a receptor   410 aa 399 aa 28.1 %

Obtained from network model

Ranking Plot


Putative Targets List


Species Potential target Raw Global Species
Loa Loa (eye worm) phosphotyrosine protein phosphatase 0.0469 1 0.5
Trichomonas vaginalis low molecular weight protein tyrosine phosphatase, putative 0.0469 1 0.5
Trichomonas vaginalis low molecular weight protein tyrosine phosphatase, putative 0.0469 1 0.5
Mycobacterium tuberculosis Phosphotyrosine protein phosphatase PtpA (protein-tyrosine-phosphatase) (PTPase) (LMW phosphatase) 0.0408 0 0.5
Mycobacterium ulcerans phosphotyrosine protein phosphatase PtpA 0.0469 1 0.5
Trichomonas vaginalis low molecular weight protein-tyrosine-phosphatase, putative 0.0469 1 0.5
Entamoeba histolytica protein tyrosine phosphatase, putative 0.0469 1 0.5
Trichomonas vaginalis low molecular weight protein tyrosine phosphatase, putative 0.0469 1 0.5
Giardia lamblia Low molecular weight protein-tyrosine-phosphatase 0.0469 1 0.5
Onchocerca volvulus 0.0469 1 0.5
Trichomonas vaginalis low molecular weight protein-tyrosine-phosphatase, putative 0.0469 1 0.5
Entamoeba histolytica protein tyrosine phosphatase, putative 0.0469 1 0.5
Trichomonas vaginalis low molecular weight protein-tyrosine-phosphatase, putative 0.0469 1 0.5

Activities

Activity type Activity value Assay description Source Reference
Ki (binding) = 15.1 uM Binding affinity against adenosine A2A receptor from rat brain. ChEMBL. 7752196
Ki (binding) = 22.9 uM Binding affinity against adenosine A1 receptor from rat brain. ChEMBL. 7752196
Ki (binding) = 62.5 uM Binding affinity against adenosine A3 receptor from rat brain. ChEMBL. 7752196

Phenotypes

Whole-cell/tissue/organism interactions

We have no records of whole-cell/tissue assays done with this compound What does this mean?

Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.

Annotated phenotypes:

We have no manually annotated phenotypes for this drug. What does this mean? / Care to help?
In TDR Targets, information about phenotypes that are caused by drugs, or by genetic manipulation of cells (e.g. gene knockouts or knockdowns) is manually curated from the literature. These descriptions help to describe the potential of the target for drug development. If no information is available for this gene or if the information is incomplete, this may mean that i) the papers containing this information either appeared after the curation effort for this organism was carried out or they were inadvertently missed by curators; or that ii) the curation effort for this organism has not yet started.
 
In any case, if you have information about papers containing relevant validation data for this target, please log in using your TDR Targets username and password and send them to us using the corresponding form in this page (only visible to registered users) or contact us.

External resources for this compound

Bibliographic References

No literature references available for this target.

If you have references for this compound, please enter them in a user comment (below) or Contact us.